0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover710.71%IV-371.70%PremiumAug 16, 2024Expiry Date3.94Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.4665Delta0.2051Gamma0.25Leverage Ratio-0.0155Theta-0.0021Rho-0.11Eff Leverage0.0011Vega
Microbot Medical Stock Discussion
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
Microbot Medical Inc. (Nasdaq: MBOT) has completed the enrollment of clinical sites for its pivotal human clinical trial of the LIBERTY® Endovascular Robotic Surgical System. Memorial Sloan Kettering Cancer Center in New York City joins Brigham and Women's Hospital in Boston and Baptist Hospital of Miami as the...
Benzinga-Second Site In Company's Pivotal Human Clinical Trial, Following Brigham & Women's Hospital, Supporting Future FDA Submission For Commercialization
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
Microbot Medical (Nasdaq: MBOT) announced the successful enrollment of the first patient in its pivotal human clinical trial for the LIBERTY® Endovascular Robotic Surgical System. The procedure was conducted at Brigham and Women’s Hospital (BWH) in Boston, led by Dr. Dmitry Rabkin. This trial, part of an Investigational Device Exemption (IDE), aims to gather data to support the future ...
3 MINUTES AGO, 8:20 AM EDT
VIA GLOBENEWSWIRE
Microbot Medical Partners With Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
No comment yet